Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries

BACKGROUND: Adverse effects from childhood leukemia treatment may persist or present years after cure from cancer. We provide a comprehensive evaluation of subsequent hospitalization in five-year survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic mye...

Full description

Bibliographic Details
Published in:JNCI: Journal of the National Cancer Institute
Main Authors: Sørensen, Gitte Vrelits, Winther, Jeanette Falck, Licht, Sofie de Fine, Andersen, Klaus Kaae, Holmqvist, Anna Sällfors, Madanat-Harjuoja, Laura M, Tryggvadottir, Laufey, Bautz, Andrea, Lash, Timothy L, Hasle, Henrik
Format: Article in Journal/Newspaper
Language:English
Published: 2019
Subjects:
Online Access:https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5
https://doi.org/10.1093/jnci/djz016
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748786/pdf/djz016.pdf
id ftuniaarhuspubl:oai:pure.atira.dk:publications/ae3bb883-88b1-4e78-809a-b094bf1568e5
record_format openpolar
spelling ftuniaarhuspubl:oai:pure.atira.dk:publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 2024-06-23T07:54:04+00:00 Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries Sørensen, Gitte Vrelits Winther, Jeanette Falck Licht, Sofie de Fine Andersen, Klaus Kaae Holmqvist, Anna Sällfors Madanat-Harjuoja, Laura M Tryggvadottir, Laufey Bautz, Andrea Lash, Timothy L Hasle, Henrik 2019-02-11 https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 https://doi.org/10.1093/jnci/djz016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748786/pdf/djz016.pdf eng eng https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5 info:eu-repo/semantics/openAccess Sørensen , G V , Winther , J F , Licht , S D F , Andersen , K K , Holmqvist , A S , Madanat-Harjuoja , L M , Tryggvadottir , L , Bautz , A , Lash , T L & Hasle , H 2019 , ' Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries ' , Journal of the National Cancer Institute , vol. 111 , no. 9 , djz016 , pp. 943-951 . https://doi.org/10.1093/jnci/djz016 article 2019 ftuniaarhuspubl https://doi.org/10.1093/jnci/djz016 2024-06-04T14:24:06Z BACKGROUND: Adverse effects from childhood leukemia treatment may persist or present years after cure from cancer. We provide a comprehensive evaluation of subsequent hospitalization in five-year survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). METHODS: In the Adult Life after Childhood Cancer in Scandinavia Study, we identified 4003 five-year survivors diagnosed with childhood leukemia 1970-2008 in Denmark, Sweden, Iceland, and Finland. Survivors and 129 828 population comparisons were followed for first-time nonpsychiatric hospitalizations for 120 disease categories in the hospital registries. Standardized hospitalization rate ratios and absolute excess rates were calculated. All statistical tests were two-sided. RESULTS: Survivors of ALL (n = 3391), AML (n = 389), and CML (n = 92) had an increased overall hospitalization rate compared with population comparisons. The rate ratio for any hospitalization was 1.95 (95% confidence interval [CI] = 1.83 to 2.07) in ALL, 3.09 (95% CI = 2.53 to 3.65) in AML, and 4.51 (95% CI = 3.03 to 6.00) in CML survivors and remained increased even 20 years from leukemia diagnosis. Corresponding absolute excess rates per 1000 person-years were 28.48 (95% CI = 24.96 to 32.00), 62.75 (95% CI = 46.00 to 79.50), and 105.31 (95% CI = 60.90 to 149.72). CONCLUSION: Leukemia survivors have an increased rate of hospitalization for medical conditions. We provide novel insight into the relative and absolute rate of hospitalization for 120 disease categories in survivors of ALL, AML, and CML, which are likely to be informative for both survivors and healthcare providers. Article in Journal/Newspaper Iceland Aarhus University: Research JNCI: Journal of the National Cancer Institute 111 9 943 951
institution Open Polar
collection Aarhus University: Research
op_collection_id ftuniaarhuspubl
language English
description BACKGROUND: Adverse effects from childhood leukemia treatment may persist or present years after cure from cancer. We provide a comprehensive evaluation of subsequent hospitalization in five-year survivors of childhood acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). METHODS: In the Adult Life after Childhood Cancer in Scandinavia Study, we identified 4003 five-year survivors diagnosed with childhood leukemia 1970-2008 in Denmark, Sweden, Iceland, and Finland. Survivors and 129 828 population comparisons were followed for first-time nonpsychiatric hospitalizations for 120 disease categories in the hospital registries. Standardized hospitalization rate ratios and absolute excess rates were calculated. All statistical tests were two-sided. RESULTS: Survivors of ALL (n = 3391), AML (n = 389), and CML (n = 92) had an increased overall hospitalization rate compared with population comparisons. The rate ratio for any hospitalization was 1.95 (95% confidence interval [CI] = 1.83 to 2.07) in ALL, 3.09 (95% CI = 2.53 to 3.65) in AML, and 4.51 (95% CI = 3.03 to 6.00) in CML survivors and remained increased even 20 years from leukemia diagnosis. Corresponding absolute excess rates per 1000 person-years were 28.48 (95% CI = 24.96 to 32.00), 62.75 (95% CI = 46.00 to 79.50), and 105.31 (95% CI = 60.90 to 149.72). CONCLUSION: Leukemia survivors have an increased rate of hospitalization for medical conditions. We provide novel insight into the relative and absolute rate of hospitalization for 120 disease categories in survivors of ALL, AML, and CML, which are likely to be informative for both survivors and healthcare providers.
format Article in Journal/Newspaper
author Sørensen, Gitte Vrelits
Winther, Jeanette Falck
Licht, Sofie de Fine
Andersen, Klaus Kaae
Holmqvist, Anna Sällfors
Madanat-Harjuoja, Laura M
Tryggvadottir, Laufey
Bautz, Andrea
Lash, Timothy L
Hasle, Henrik
spellingShingle Sørensen, Gitte Vrelits
Winther, Jeanette Falck
Licht, Sofie de Fine
Andersen, Klaus Kaae
Holmqvist, Anna Sällfors
Madanat-Harjuoja, Laura M
Tryggvadottir, Laufey
Bautz, Andrea
Lash, Timothy L
Hasle, Henrik
Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
author_facet Sørensen, Gitte Vrelits
Winther, Jeanette Falck
Licht, Sofie de Fine
Andersen, Klaus Kaae
Holmqvist, Anna Sällfors
Madanat-Harjuoja, Laura M
Tryggvadottir, Laufey
Bautz, Andrea
Lash, Timothy L
Hasle, Henrik
author_sort Sørensen, Gitte Vrelits
title Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
title_short Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
title_full Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
title_fullStr Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
title_full_unstemmed Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries
title_sort long-term risk of hospitalization among five-year survivors of childhood leukemia in the nordic countries
publishDate 2019
url https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5
https://doi.org/10.1093/jnci/djz016
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748786/pdf/djz016.pdf
genre Iceland
genre_facet Iceland
op_source Sørensen , G V , Winther , J F , Licht , S D F , Andersen , K K , Holmqvist , A S , Madanat-Harjuoja , L M , Tryggvadottir , L , Bautz , A , Lash , T L & Hasle , H 2019 , ' Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries ' , Journal of the National Cancer Institute , vol. 111 , no. 9 , djz016 , pp. 943-951 . https://doi.org/10.1093/jnci/djz016
op_relation https://pure.au.dk/portal/en/publications/ae3bb883-88b1-4e78-809a-b094bf1568e5
op_rights info:eu-repo/semantics/openAccess
op_doi https://doi.org/10.1093/jnci/djz016
container_title JNCI: Journal of the National Cancer Institute
container_volume 111
container_issue 9
container_start_page 943
op_container_end_page 951
_version_ 1802646020300996608